Optimizing Pain Self-Management in Total Knee Arthroplasty
1 other identifier
interventional
150
1 country
1
Brief Summary
The purpose of this study is to investigate the efficacy of a positive affect enhancing intervention designed to reduce pain and augment reward system function in knee osteoarthritis (KOA) patients undergoing total knee arthroplasty (TKA). The scientific premise is that patient use of a positive emotion generative practice - savoring meditation, which has been demonstrated to reduce pain in experimental laboratory settings, enhanced with a pain neuroscience education component about reward system dysfunction as a chronic pain mechanism - is optimally suited to reduce postsurgical pain and augment reward system functioning relative to a Pain Self-Management and Education (PSME) condition. We will randomize 150 patients with KOA undergoing unilateral TKA to a brief, 4-session (20-30 minutes each) course of Savoring Meditation (SM; n = 75) or PSME (n = 75) delivered remotely by trained interventionists in a one-on-one format. We will assess pain and as well as pain-related risk and protective factors both via questionnaire and via weeklong ecological momentary assessment (EMA) data bursts on the following schedule: baseline, post-surgery, and 3-month follow-up. In addition, participants will attend laboratory testing sessions at baseline and 6-weeks post-surgery, during which affective pain modulation and electroencephalographic (EEG) brain biomarkers associated with pain and affect will be recorded. Participants in SM be encouraged to practice their savoring for 5 minutes/day during the week following surgery, as well as to use it to manage pain flares in a self-directed manner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2023
CompletedFirst Posted
Study publicly available on registry
September 14, 2023
CompletedStudy Start
First participant enrolled
November 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
December 6, 2023
November 1, 2023
2.8 years
September 7, 2023
November 29, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Numeric Rating Scale for Clinical Pain
Average pain intensity on numeric rating scale (range of 0-100; higher scores indicate greater pain), aggregated across Ecological Momentary Assessment observations
Baseline to 3 months post-surgery
Opioid Use
Morphine Equivalent Units per day, as assessed with Ecological Momentary Assessment
Baseline to 3-months post-surgery
Secondary Outcomes (3)
Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR)
Baseline to 3 months post-surgery
Positive and Negative Outcome Schedule-X (PANAS-X) Joviality Subscale
Baseline to 3-months post-surgery
Snaith-Hamilton Pleasure Scale (SHAPS)
Baseline to 3-months post-surgery
Study Arms (2)
Savoring Meditation
EXPERIMENTALA 4-session meditation intervention in which participants are trained to generate positive emotional states and focus their awareness on those states throughout the meditation.
Pain Self-Management and Education
OTHEREducation Control
Interventions
Participants will learn about pain neuroscience and will learn/practice a positive emotion generative practice (Savoring Meditation).
Participants will learn about the biopsychosocial drivers of chronic pain.
Eligibility Criteria
You may qualify if:
- years old.
- Have a physician-confirmed treatment plan to undergo unilateral TKA along with physician-confirmed knee osteoarthritis diagnosis.
- Willingness and ability to comply with scheduled sessions and study procedures
You may not qualify if:
- Member of a vulnerable population including pregnant women, children, prisoners, cognitively impaired, and non-English-speaking subjects.
- Current unstable, severe medical comorbidity.
- Current severe psychiatric comorbidity (e.g., schizophrenia, psychosis, or other unstable psychiatric disorder).
- Current severe alcohol or substance use disorder.
- Weekly or more frequent use of opioids in the past 30 days (other than tramadol and/or codeine) for therapeutic or non-therapeutic purposes.
- Other surgery of the affected knee in the last 6 months.
- Previous TKA.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fontaine Research Park
Charlottesville, Virginia, 22903, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Harold Carron Professor
Study Record Dates
First Submitted
September 7, 2023
First Posted
September 14, 2023
Study Start
November 27, 2023
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2027
Last Updated
December 6, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Data will become available after the study is complete and the primary outcomes manuscript has been published.
- Access Criteria
- Access will be granted after a Data Use Agreement has been executed.
Deidentified data will be shared upon reasonable request from other researchers, and after a data use agreement has been executed between institutions.